Eric Warren - Jul 19, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Commercial Officer
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Jul 19, 2022
Transactions value $
-$2,837
Form type
4
Date filed
7/20/2022, 04:27 PM
Previous filing
Jun 21, 2022
Next filing
Aug 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$2.84K -431 -0.8% $6.58* 53.2K Jul 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.